A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
The collaborative study, conducted by researchers from academia and industry and funded by grants from the National Cancer Institute, used pancreatic cancer cells to investigate the effect of heating and freezing on cell death. The research was conducted by Robert Van Buskirk and John Baust, professors of biological sciences and directors at Binghamton University’s Institute of Biomedical Technology, and Kenneth Baumann, a graduate student studying biology.
“How do we solve the problem of pancreatic cancer when it comes to trying to get rid of the tumor, when chemo and radiation just simply doesn’t work?” said Van Buskirk. “The whole idea is, can one come up with a different surgical intervention that’s less invasive and more effective?
“In order to figure that out, you can commercially obtain pancreatic cancer cells and grow them on specialized plasticware,” Van Buskirk said. “The basic question is, are both freezing and heat in combination more effective than freezing or heat alone? If you freeze pancreatic cancer cells like you do in cryoablation, a lot of them die, but some will survive and regrow. If you heat them, they’ll die, but again some will come back. But with dual-thermal ablation, for reasons that we do not yet understand, more die and don’t come back. In fact, over time, cells that survive the initial insult continue to die.”
“What we’ve observed is that we are able to achieve complete cell death using a combination of heating and then freezing at temperatures that alone would not be lethal to kill pancreatic cancer cells,” said Baumann.
Researchers heated and froze cancer cells and looked at the effect, using various technologies to determine the level of cell death, on regrowth as well as which cell stress pathways were activated.
“Using a variety of assays, we are able to determine the initial level of cell death as well as to what extent the surviving population is able to regrow,” Baumann said. “We were also able to determine the specific paths of cell death activated as a result of the dual thermal exposure.”
“When cells are disturbed—which means they are frozen or they see heat—various cell stress pathways are activated,” said Van Buskirk. “The interesting thing about cells, especially cancer cells, is that they will activate pathways to protect themselves. The objective of this line of molecular-based research is to find out which stress pathways are activated in pancreatic cancer cells so that we can better understand why dual-thermal ablation appears to be more effective.”
“Current studies are focused on elucidating which stress pathways specifically cause these cells to die or what is keeping them alive. That way, we can optimize this treatment to be as effective as possible against pancreatic cancer,” Baumann said.
According to Van Buskirk, modulating these stress pathways is the key to making the heating and freezing ablation process more effective. This could lead to the development of a new way to remove cancerous pancreatic tumors.
In addition to the cell molecular research, several members of the study team are working on developing new catheter technologies to deliver this ablative therapy to patients. “If a very thin catheter can be developed to target the tumor, and if we understand how pancreatic cancer responds to ablation at the molecular level, then we may be able to develop a new therapy to approach something that has been completely unapproachable, the targeted killing of a tumor in a very difficult place: the pancreas,” said Van Buskirk.
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- NanOlogy to Present Interim Data for Pancreatic Cancer and Mucinous Cystic Neoplasms of the Pancreas with Local Injection of NanoPac®on October 15, 2019 at 5:08 pm
The pancreatic cancer abstract presents interim clinical data on intratumoral delivery of NanoPac for treatment of locally advanced pancreatic cancer on October 29 th at 8:40AM by Simon K. Lo, MD ...
- Man receives his college degree hours before dying of pancreatic canceron October 15, 2019 at 12:36 pm
This man was diagnosed with an aggressive cancer and became unable to finish his final class -- then the school system did something incredibly touching ...
- Global Pancreatic Cancer Therapeutics Diagnostics Market Growth, Trends and Forecast 2016-2022on October 15, 2019 at 5:02 am
The uncontrolled growth of cells in the pancreas causes pancreatic cancer. It is an abnormal, unrestrained growth of cells which leads to formation of lumps in the tissues, usually referred to as ...
- Pancreatic Cancer Therapeutics Market Analysis Reveals Explosive Growth by 2025 | Merck, Celgene, Novartison October 15, 2019 at 3:36 am
Unlock new opportunities in Pancreatic Cancer Therapeutics Market; the latest release from HTF MI highlights the key market trends significant to the growth prospects, Let us know if any specific ...
- The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic canceron October 15, 2019 at 2:14 am
Unfortunately, despite these advances for many forms of cancer, immune therapy approaches for patients with pancreatic ductal adenocarcinoma (PDAC) are lacking. With a median survival of 6 months and ...
- This Is Why Pancreatic Cancer Is So Hard to Treaton October 10, 2019 at 10:00 pm
When Jeopardy! host Alex Trebek announced that he has late-stage pancreatic cancer in March 2019, his fans were stunned. The cancer is incredibly tough to beat, and although Trebek was initially ...
- Vaccine against gastrin may slow spread of pancreatic canceron October 10, 2019 at 2:22 pm
New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American ...
- Machine learning can differentiate types of pancreatic cancer tumorson October 9, 2019 at 8:38 pm
An algorithm can identify from MRI images different subtypes of pancreatic cancer, aiding clinicians who plot prospective treatments. Researchers say that knowledge of the specific type of a patient’s ...
- Three Drugs Beats Two in Advanced Pancreatic Canceron October 9, 2019 at 10:11 am
A small trial in patients with advanced pancreatic cancer found that adding a third chemotherapy to the doublet that is currently the standard of care resulted in substantial tumor shrinkage and ...
- Combination treatment cures pancreatic cancer, reprograms the immune systemon October 8, 2019 at 2:34 pm
A University of Rochester Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram ...
via Bing News